Finding a suitable donor is one of the most important steps in an allogeneic bone marrow or blood stem cell transplant. If you have been told that there is no fully matched donor, it can be frightening to think that a transplant may no longer be possible. Fortunately, not having a fully matched donor does not necessarily mean that you cannot have a transplant.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Advances in transplant medicine have expanded the number of donor options available. Depending on your disease, urgency, overall health and the donor options available, your transplant team may consider a half-matched family donor, a partially matched unrelated donor, or an umbilical cord blood unit.
If you are learning about transplantation, our Bone Marrow Transplant guide provides a broader overview of the transplant process and its uses.
Why Is a Fully Matched Donor Important?
Before an allogeneic transplant, doctors compare the patient's human leukocyte antigen (HLA) markers with those of potential donors. HLA markers help the immune system distinguish the body's own cells from cells that do not belong there. The closer the donor and recipient are matched, the more closely the donated immune and blood-forming cells can be expected to interact with the patient's body.
A close match can reduce certain transplant-related risks, including complications related to immune incompatibility. However, a perfect match is not always available. HLA types are inherited, and the likelihood of finding a suitable unrelated donor can vary between individuals and populations.
How Likely Is It to Find a Fully Matched Family Donor?
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Brothers and sisters who share the same biological parents are usually the first family members considered for HLA testing. Each full sibling has approximately a 1 in 4 chance of being a full HLA match.
This means that many patients who need an allogeneic transplant will not have a fully matched sibling. Parents and children are different. Because a child inherits one set of HLA markers from each parent, a parent or child is generally a half-match rather than a full match. This is important because a half-matched family member may still be a viable donor for certain patients.
What Happens When No Fully Matched Donor Is Found?
The donor search does not necessarily stop when a fully matched sibling is unavailable. Your transplant team may look at several alternative sources of blood-forming stem cells. The choice is individualised and can depend on how quickly the transplant is needed, your disease, your age and health, available donors, HLA characteristics and the transplant centre's experience.
The main alternatives include:
- Haploidentical or half-matched family donor
- Matched or partially matched unrelated donor
- Umbilical cord blood
Option 1: A Half-Matched Family Donor
A haploidentical transplant uses blood-forming stem cells from a donor who shares approximately half of the patient's HLA markers. This donor is often a parent, child or sibling.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
For many years, a half-matched donor was considered much less desirable because of concerns about complications caused by differences between the donor's immune system and the recipient's tissues.
Modern transplant techniques have changed this significantly. Special methods of preventing and controlling graft-versus-host disease (GVHD) have made haploidentical transplantation a practical option for many patients.
One approach uses medication after transplantation to control donor immune cells and reduce the risk of serious GVHD. The exact conditioning and GVHD-prevention strategy varies between patients and transplant centres.
Why can a half-match be useful?
The major advantage is availability. Almost everyone has an immediate family member who could potentially provide a half-match. This can be particularly important when a patient needs a transplant relatively soon and waiting for a fully matched unrelated donor may not be the best option. However, not every half-matched family member is automatically suitable. The transplant team performs additional testing before selecting the donor.
Option 2: A Partially Matched Unrelated Donor
If a fully matched unrelated donor cannot be found, a mismatched unrelated donor may sometimes be considered. Modern transplant strategies have improved the ability to use partially matched unrelated donors safely in selected patients.
The degree and location of the HLA mismatch matter, and the transplant team may consider additional donor characteristics when deciding whether a particular donor is appropriate.
Option 3: Umbilical Cord Blood
Umbilical cord blood is another possible source of blood-forming stem cells. Cord blood collected after childbirth can be stored in cord blood banks and later used for patients who need a transplant. One important difference is that cord blood does not always need to be as closely HLA-matched as an adult donor's cells.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
This can make cord blood useful when a suitable adult donor cannot be found. It can also be particularly useful when a transplant is needed relatively quickly because an available cord blood unit has already been collected and stored.
However, cord blood has its own limitations, including the number of blood-forming cells available in a unit. Whether it is appropriate depends on the patient's size, disease, transplant plan and available cord blood units.
Does the Donor Have to Be a Family Member?
No. An allogeneic transplant can use cells from a related donor or an unrelated donor. If there is no suitable family donor, the transplant team can search donor registries for an unrelated donor. Cord blood banks may also be searched for a suitable unit. Therefore, not having a matching brother, sister, parent or child does not automatically mean that an allogeneic transplant is impossible.
What If Several Donors Are Available?
Sometimes the situation is not simply “matched donor versus no donor.” A patient may have several possible donors, including a half-matched relative and one or more unrelated donors. In that situation, the transplant team considers more than HLA matching.
Factors that may influence donor selection include:
- Degree and type of HLA matching
- Donor age
- Availability and timing
- Donor health
- Presence of donor-specific antibodies
- Blood group and other compatibility considerations
- Previous sensitisation or other patient-specific factors
- The patient's disease and urgency of transplantation
- The transplant centre's experience with a particular donor source
Does a Half-Matched Transplant Work as Well as a Fully Matched Transplant?
Outcomes have improved substantially with modern approaches to GVHD prevention and supportive care. For appropriately selected patients, transplantation using a half-matched or other alternative donor can provide an effective route to allogeneic transplantation when a fully matched donor is unavailable.
However, it would be misleading to say that every alternative donor transplant has exactly the same risks or outcomes as a fully matched transplant. The result depends on the disease, patient characteristics, donor type, transplant technique and experience of the treating centre. The important change is that a lack of a fully matched donor no longer automatically means that transplant cannot be considered.
Will a Half-Matched Donor Increase the Risk of GVHD?
HLA differences are one factor associated with graft-versus-host disease, in which donor immune cells attack tissues in the recipient's body. Because a haploidentical donor is only partially matched, controlling donor immune reactions is an important part of the transplant strategy.
Modern GVHD-prevention approaches have significantly expanded the use of haploidentical transplantation. Medication given around and after transplantation can be used to reduce harmful immune reactions.
Even with these strategies, GVHD remains an important potential complication, and patients are monitored closely for signs of it during and after transplantation.
Can the Donor Search Take Too Long?
Sometimes, timing becomes an important part of the donor decision. For diseases that require transplantation relatively quickly, waiting indefinitely for a perfect donor may not always be the best strategy if a safe alternative donor is already available.
Modern donor-selection approaches increasingly consider the likelihood of finding a fully matched donor alongside alternative donor options. This can allow the transplant team to plan earlier rather than waiting until the preferred option is no longer realistic.
The urgency of transplantation depends heavily on the underlying disease and its response to treatment, so the appropriate timing is different for every patient.
Does Your Ethnic Background Affect the Chance of Finding a Match?
It can. HLA characteristics are inherited and vary among populations. As a result, people from some ethnic or ancestral backgrounds may have a lower probability of finding a fully matched unrelated donor in a particular registry. This is one reason donor registries continue to work toward greater diversity among registered donors.
For patients who cannot find a fully matched donor, alternative approaches such as haploidentical transplantation and other partially matched donor strategies can therefore be particularly important.
What Happens Before an Alternative Donor Is Approved?
Finding a potential donor is only the beginning. The transplant team performs additional testing to determine whether the donor is suitable and whether the transplant can be performed safely.
This may involve confirming HLA typing, evaluating the donor's health and reviewing other compatibility factors. The patient also undergoes assessments to determine whether they are medically ready for transplantation.
Once the donor and transplant approach are selected, the team plans the conditioning treatment, stem-cell collection, transplant and GVHD-prevention strategy.
What If No Suitable Donor Is Found at All?
In some cases, the transplant team may still not identify a suitable donor or cell source. What happens next depends entirely on the underlying disease and the reason transplantation was being considered.
Doctors may continue evaluating alternative donor or cell sources, consider a clinical trial, or discuss other disease-specific treatments when transplantation is not currently possible.
This is why an initial statement that there is “no fully matched donor” should not automatically be interpreted as “there is no transplant option.” These are two very different situations.
The Bottom Line
Not having a fully matched bone marrow donor does not necessarily mean that a transplant is no longer possible. Modern transplant medicine has expanded donor choices beyond the traditional fully matched sibling. Depending on your circumstances, a half-matched parent, child or sibling, a partially matched unrelated donor, or an umbilical cord blood unit may provide another route to allogeneic transplantation.
The choice is not based on HLA matching alone. Your disease, treatment urgency, donor availability, donor health, additional compatibility factors and the transplant centre's experience all contribute to the decision.
Most importantly, a donor search should not be viewed as simply finding a “perfect match” or finding nothing. Today, transplant teams can use several strategies to identify an appropriate donor when a fully matched option is unavailable. For some patients, these alternative donor approaches can make transplantation possible when it might previously have been ruled out.
